• Celebrate the holiday season with AcceGen’s highest discounts of the year. Merry Christmas and Happy New Year!

    Learn More
Transfected Stable Cell Lines

RFP Expressing Human Brain Glioblastoma Cells (LN-229)

  • BSL

    1

  • 82
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options

Human Brain Glioblastoma Cells (LN-229) were isolated and cultured in AcceGen’s professional laboratory. Donor: Human Brain Glioblastoma of a 19-year old Caucasian female. RFP-Human Brain Glioblastoma Cells (LN-229) are selected from the human brain glioblastoma cells (LN-229) and transfected with RFP expressing lentiviruses resistant to puromycin. Each vial contains at least 5 x 10^5 cell/vial.

Species

Human

Cat.No

ABC-TC073L

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Transfected Stable Cell Lines
Size/Quantity

1 vial

Cell Type

Glioblastoma Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Brain

Disease

Glioblastoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Reporter Stable Cell Line

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

View More
View Product Image

Application

  • For research use only

Inquiring RFP Expressing Human Brain Glioblastoma Cells (LN-229)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research
AcceGen Scroll Top Button